Vascular Solutions Inc. (NASDAQ:VASC) shares reached a new 52-week high during trading on Thursday . The stock traded as high as $47.75 and last traded at $47.70, with a volume of 28,117 shares traded. The stock had previously closed at $47.07.

Several research analysts have commented on VASC shares. Zacks Investment Research lowered Vascular Solutions from a “buy” rating to a “hold” rating in a research report on Wednesday, June 29th. Piper Jaffray Cos. lifted their price target on Vascular Solutions from $45.00 to $49.00 and gave the stock an “overweight” rating in a research report on Tuesday, July 26th. Sidoti lowered Vascular Solutions from a “buy” rating to a “neutral” rating and set a $47.00 price target on the stock. in a research report on Tuesday, July 12th. TheStreet upgraded Vascular Solutions from a “hold” rating to a “buy” rating in a research note on Monday, July 25th. Finally, Canaccord Genuity reiterated a “buy” rating on shares of Vascular Solutions in a research note on Wednesday, August 10th. One research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus target price of $47.38.

The company has a market cap of $824.88 million and a P/E ratio of 87.33. The firm’s 50-day moving average is $44.84 and its 200 day moving average is $36.65.

Vascular Solutions (NASDAQ:VASC) last released its quarterly earnings data on Monday, July 25th. The medical device company reported $0.33 earnings per share for the quarter, topping the consensus estimate of $0.30 by $0.03. The company had revenue of $41.20 million for the quarter, compared to the consensus estimate of $41.40 million. The business’s revenue was up 9.7% compared to the same quarter last year. During the same period in the prior year, the business earned $0.29 earnings per share. Analysts predict that Vascular Solutions Inc. will post $1.24 earnings per share for the current fiscal year.

In other news, VP William Rutstein sold 10,011 shares of the firm’s stock in a transaction on Wednesday, July 27th. The stock was sold at an average price of $46.26, for a total transaction of $463,108.86. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO Howard Root sold 40,000 shares of the firm’s stock in a transaction on Wednesday, July 27th. The stock was sold at an average price of $45.11, for a total value of $1,804,400.00. Following the sale, the chief executive officer now directly owns 347,840 shares of the company’s stock, valued at $15,691,062.40. The disclosure for this sale can be found here.

Vascular Solutions, Inc is a medical device company focused on bringing clinically advanced solutions to the market for treating coronary and peripheral vascular disease. The Company’s product line consists of devices and services that are sold to interventional cardiologists, interventional radiologists, electrophysiologists and vein practices around the world.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.